These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9359432)

  • 21. Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation.
    Stipp CS; Litwack ED; Lander AD
    J Cell Biol; 1994 Jan; 124(1-2):149-60. PubMed ID: 8294498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell surface heparan sulfate proteoglycans and lipoprotein metabolism.
    Kolset SO; Salmivirta M
    Cell Mol Life Sci; 1999 Nov; 56(9-10):857-70. PubMed ID: 11212344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of cell surface heparin sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells.
    Shimada K; Gill PJ; Silbert JE; Douglas WH; Fanburg BL
    J Clin Invest; 1981 Oct; 68(4):995-1002. PubMed ID: 6457061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of adipocyte heparan sulfate proteoglycans with affinity for lipoprotein lipase.
    Misra KB; Kim KC; Cho S; Low MG; Bensadoun A
    J Biol Chem; 1994 Sep; 269(38):23838-44. PubMed ID: 8089154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous receptor-associated protein binds to two distinct sites on human fibroblasts but does not bind to the glycosaminoglycan residues of heparan sulfate proteoglycans.
    Vassiliou G; Stanley KK
    J Biol Chem; 1994 May; 269(21):15172-8. PubMed ID: 7515052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A carboxyl-terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor-related protein and inhibits lipase-mediated uptake of lipoprotein in cells.
    Nykjaer A; Nielsen M; Lookene A; Meyer N; Røigaard H; Etzerodt M; Beisiegel U; Olivecrona G; Gliemann J
    J Biol Chem; 1994 Dec; 269(50):31747-55. PubMed ID: 7989348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain.
    Saunders S; Paine-Saunders S; Lander AD
    Dev Biol; 1997 Oct; 190(1):78-93. PubMed ID: 9331333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans.
    Veugelers M; De Cat B; Ceulemans H; Bruystens AM; Coomans C; Dürr J; Vermeesch J; Marynen P; David G
    J Biol Chem; 1999 Sep; 274(38):26968-77. PubMed ID: 10480909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase.
    Parthasarathy N; Goldberg IJ; Sivaram P; Mulloy B; Flory DM; Wagner WD
    J Biol Chem; 1994 Sep; 269(35):22391-6. PubMed ID: 8071367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.
    Friedrich MV; Göhring W; Mörgelin M; Brancaccio A; David G; Timpl R
    J Mol Biol; 1999 Nov; 294(1):259-70. PubMed ID: 10556044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells.
    Kishibe J; Yamada S; Okada Y; Sato J; Ito A; Miyazaki K; Sugahara K
    J Biol Chem; 2000 May; 275(20):15321-9. PubMed ID: 10809767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human ryudocan from endothelium-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor.
    Kojima T; Katsumi A; Yamazaki T; Muramatsu T; Nagasaka T; Ohsumi K; Saito H
    J Biol Chem; 1996 Mar; 271(10):5914-20. PubMed ID: 8621465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of lipoproteins with heparan sulfate proteoglycans and with lipoprotein lipase. Studies by surface plasmon resonance technique.
    Lookene A; Savonen R; Olivecrona G
    Biochemistry; 1997 Apr; 36(17):5267-75. PubMed ID: 9136889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Slit protein interactions with glypican-1.
    Ronca F; Andersen JS; Paech V; Margolis RU
    J Biol Chem; 2001 Aug; 276(31):29141-7. PubMed ID: 11375980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue factor pathway inhibitor and protease nexin-1 are major factor Xa binding proteins on the HepG2 cell surface.
    Kazama Y; Komiyama Y; Kisiel W
    Blood; 1993 Feb; 81(3):676-82. PubMed ID: 8381308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
    Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor.
    Mukherjee M; Kakkar VV
    Thromb Haemost; 1999 Dec; 82(6):1648-51. PubMed ID: 10613650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans.
    Shakibaei M; Frevert U
    J Exp Med; 1996 Nov; 184(5):1699-711. PubMed ID: 8920859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two receptor systems are involved in the plasma clearance of tissue factor pathway inhibitor in vivo.
    Narita M; Bu G; Olins GM; Higuchi DA; Herz J; Broze GJ; Schwartz AL
    J Biol Chem; 1995 Oct; 270(42):24800-4. PubMed ID: 7559599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.